Literature DB >> 12137780

Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions.

Ronald H Lekanne Deprez1, Arnoud C Fijnvandraat, Jan M Ruijter, Antoon F M Moorman.   

Abstract

The recent development of real-time PCR has offered the opportunity of sensitive and accurate quantification of mRNA levels that is crucial in biomedical research. Although reverse transcription (RT)-PCR is at present the most sensitive method available, many low abundant mRNAs are, although detectable, often not quantifiable. Here we report an improved two-step real-time RT-PCR procedure using SYBR green I and the LightCycler that better permits accurate quantification of mRNAs. Omission of dithiothreitol from the cDNA synthesis reaction was found to be crucial. This resulted in a lower cycle number at which the cDNA level is determined (C(T) value), steeper amplification curves, and removal of background fluorescence in the subsequent PCR. In addition, the choice of the cDNA priming oligo can improve detection sensitivity even further. In contrast to hexamer primer usage, both gene-specific and oligo-dT(VN) priming were very efficient and accurate, with gene-specific priming being the most sensitive. Finally, accurate quantification of mRNAs by real-time PCR using SYBR green I requires verification of the specificity of PCR by both melting curve and gel analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137780     DOI: 10.1016/s0003-2697(02)00021-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  76 in total

1.  Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner.

Authors:  Petra E M H Habets; Danielle E W Clout; Ronald H Lekanne Deprez; Marian A van Roon; Antoon F M Moorman; Vincent M Christoffels
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Quantitative real-time polymerase chain reaction: methodical analysis and mathematical model.

Authors:  Stefan Wilkening; Augustinus Bader
Journal:  J Biomol Tech       Date:  2004-06

Review 3.  Detection and quantification of gene expression in environmental bacteriology.

Authors:  Freddie H Sharkey; Ibrahim M Banat; Roger Marchant
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

Review 4.  Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction.

Authors:  Stephen A Bustin; Tania Nolan
Journal:  J Biomol Tech       Date:  2004-09

5.  Two-Step versus One-Step RNA-to-CT 2-Step and One-Step RNA-to-CT 1-Step: validity, sensitivity, and efficiency.

Authors:  Nasser Al-Shanti; Amarjit Saini; Claire E Stewart
Journal:  J Biomol Tech       Date:  2009-07

Review 6.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Single-cell qPCR on dispersed primary pituitary cells -an optimized protocol.

Authors:  Kjetil Hodne; Trude M Haug; Finn-Arne Weltzien
Journal:  BMC Mol Biol       Date:  2010-11-12       Impact factor: 2.946

8.  Quantitative assessment of the sensitivity of various commercial reverse transcriptases based on armored HIV RNA.

Authors:  John B A Okello; Linda Rodriguez; Debi Poinar; Kirsten Bos; Andrew L Okwi; Gabriel S Bimenya; Nelson K Sewankambo; Kenneth R Henry; Melanie Kuch; Hendrik N Poinar
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

9.  Generation and characterization of human insulin-releasing cell lines.

Authors:  Leticia Labriola; Maria G Peters; Karin Krogh; Iván Stigliano; Letícia F Terra; Cecilia Buchanan; Marcel C C Machado; Elisa Bal de Kier Joffé; Lydia Puricelli; Mari C Sogayar
Journal:  BMC Cell Biol       Date:  2009-06-19       Impact factor: 4.241

10.  Selective control of primer usage in multiplex one-step reverse transcription PCR.

Authors:  Elena Hidalgo Ashrafi; Joyclyn Yee; Natasha Paul
Journal:  BMC Mol Biol       Date:  2009-12-30       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.